May 29, 2020

The Post Wired

News On Trending

Red Spotlight: Phio Pharmaceuticals Corp. (NASDAQ:PHIO)

Spread the love

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) noticed downward change of -3.12% to $0.45 along volume of 250539 shares in recent session compared to an average volume of 685.73K. The stock observed return of -2.89% in 5 days trading activity. The stock was at 8.14% over one month performance. PHIO’s shares are at 32.86% for the quarter and driving a -84.60% return over the course of the past year and is now at 40.95% since this point in 2018.

The average volatility for the week at 5.02% and for month was at 6.98%. There are 22.5M shares outstanding and 16.84M shares are floated in market. Right now the stock beta is 2.04.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported the appointment of Dr. John A. Barrett as the Company’s Chief Development Officer effective as of April 22nd.

Dr. Gerrit Dispersyn, President and CEO of Phio Pharmaceuticals said “I am delighted to welcome John to Phio. John is a seasoned and passionate leader who brings a wealth of experience developing immuno-oncology gene and cell therapies”. “His expertise in driving drug discovery and development in areas similar to Phio’s current R&D focus, will be invaluable as we continue to develop our self-delivering RNAi platform into innovative immuno-oncology therapeutics. I am thrilled to have someone of John’s caliber join our team, which is a testimony to the value we have developed thus far, and the potential our pipeline holds.”

Dr. Barrett added “Phio Pharmaceuticals’ self-delivering RNAi technology is an enticing modality for immuno-oncology therapeutics with a potential to replace or complement certain genetic engineering approaches. For example, the use of this technology holds promise in taking the molecular brakes off the tumor infiltrating T-cells and releasing their full therapeutic potential”. “I am excited to join Phio and welcome the opportunity to be a part of fulfilling the Company’s mission to develop truly innovative cancer treatments.”

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock identified change of 66.85% away from 52-week low price and recently located move of -85.70% off 52-week high price. It has market worth of $10.46M . PHIO stock has been recorded 11.42% away from 50 day moving average and -44.37% away from 200 day moving average. Moving closer, we can see that shares have been trading 0.36% off 20-day moving average.

Single Column Posts

2 min read

Spain's La Liga will continue on 11 June with next season beginning on 12 September, says the alliance's leader Javier Tebas. On Monday, Tebas said...

3 min read

The 125th gathering between Borussia Dortmund and Bayern Munich will without a doubt be the most foreseen match of this crowdless Bundesliga period. No less...

3 min read

Borussia Dortmund host Bayern Munich this evening in one of the biggest matches of the Bundesliga season. Bayern currently enjoy a four point lead at...

3 min read

Borussia Dortmund vs. Bayern Munich Match Info Der Klassiker is set for Tuesday at Signal Iduna Park as runner up Borussia Dortmund invites in front...

5 min read

We will give us one of the most exceptionally foreseen matches, in the Bundesliga as well as in Europe, as Borussia Dortmund lock horns with...

3 min read

How to watch Tiger vs Phil live on Kodi, Android, iOS, Fire TV Stick and other devices from US, UK, Canada and rest of the...

6 min read

On the off chance that you love golf, at that point missing the 2020 Tiger Woods versus Phil Mickelson is simply impossible. There is such...

3 min read

Tiger Woods vs Phil Mickelson II : Start time, TV channel with Tom Brady and Peyton Manning Aspect Old rivals Tiger Woods and Phil Mickelson...

3 min read

There isn't obviously superior to a Sunday evening of watching golf and sleeping, however for fans who have been denied of live games for a...

4 min read

Champions for Charity 2020 Live:: The decades-long contentions between Tom Brady and Peyton Manning proceed with the assistance of another, the one between Tiger Woods...